Clinical and laboratory evaluation of penicillin resistant Streptococcus pneumoniae in relation to the mutations of pbp1a, pbp2b and pbp2x

Kurume Medical Journal

Volumn 48, Issue 1, 2001, Pages 1-8

  Tanoue, Sachiko ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

pbp1a; pbp2b; pbp2x; Penicillin resistance; S. pneumoniae

Indexed keywords

BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CEFACLOR; CEFEPIME; CEFPODOXIME PROXETIL; CEPHEM DERIVATIVE; CILASTATIN PLUS IMIPENEM; CLARITHROMYCIN; GLYCOPEPTIDE; LEVOFLOXACIN; MACROLIDE; PENICILLIN BINDING PROTEIN; PENICILLIN DERIVATIVE; PENICILLIN G; PROTEIN PBP1A; PROTEIN PBP2B; PROTEIN PBP2X; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; UNCLASSIFIED DRUG; VANCOMYCIN;

ARTICLE; BACTERIAL VIRULENCE; BACTERIUM ISOLATION; DIAGNOSTIC VALUE; DRUG SENSITIVITY; GENE ISOLATION; GENE MUTATION; LABORATORY DIAGNOSIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PENICILLIN RESISTANCE; PREVALENCE; STRAIN DIFFERENCE; STREPTOCOCCUS PNEUMONIAE;

EID: 0034988863     PISSN: 00235679     EISSN: None     Source Type: Journal    
DOI: 10.2739/kurumemedj.48.1     Document Type: Article

References (19)

1. Lieberman D, Schlaeffer F, Boldur I et al. Multiple pathogens in adult patient admitted with community-acquired pneumonia: A one year prospective study of 346 consecutive patients. Thorax 1996; 51:179-184.
2. Hansman D, and Bullen M. A resistant pneumococcus. Lancet 1967; 2 :264-265.
3. Jacobs MR, Koornhof HJ, Robins Browne RM et al. Emergence of multiply resistant pneumococci. N Eng J Med 1978; 299:735-740.
4. Appelbaum PC. Antimicrobial resistant in Streptococcus pneumoniae: An overview. Clin Infect Dis 1992; 15:77-83.
5. Kudo F, and Sasamura Y. Acute mastoiditis in infants: penicillin-resistant Streptococcus pneumoniae and its therapy. Nippon Jibiinkoka Gakkai Kaiho 1998; 101:1075-1081. (in Japanese)
6. Tateda K, Takashima K, Miyazaki H, Matsumoto T, Hatori T et al. Noncompromised penicillin-resistant pneumococcal pneumonia CBA/J mouse model and comparative efficacies of antibiotics in this model. Antimicrob Agents Chemother 1996; 40:1520-1525.
7. Hakenbeck R, Tarpay M, and Tomasz A. Multiple changes of penicillin-binding proteins in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother 1980; 17:364-371.
8. Ubukata K, Muraki O, Igarashi A, Asahi Y, and Konno M. Identification of penicillin and other beta-lactam resistance in Streptococcus pneumoniae by polymerase chain reaction. J Inf Chemoth 1998; 3:190-197.
9. Oguri T, Misawa S, and Igari J. In vitro antimicrobial activity of oral β-lactam antibiotics against Streptococcus pneumoniae from clinical specimens. Jpn J Chemother 1995; 43:531-538. (in Japanese)
10. Ubukata K, Asahi Y, Okuzumi K, and Konno M. The Working Group for Penicillin-resistant Streptococcus pneumoniae in Japan. 1993-1995. J Infect Chemother 1996; 1:177-184.
11. Shigeno H, Yamasaki T, Nagai H, Goto Y, Tashiro T et al. A case of penicillin-resistant pneumococcal pneumonia and penicillin-binding proteins of the clinical isolates. Kansenshogaku Zasshi 1992; 66:508-515. (in Japanese)
12. Mitsui I, Tanoue S, Mitarai S, and Shishido H. Penicillin-resistant Streptococcus pneumoniae: Clinical aspects. Infect Antimicrobial 1998; 1:324-331. (in Japanese)
13. Munoz R, Dowson CG, Daniels M, Coffey TJ, Martin C et al. Genetic of resistance to third-generation cephalosporins in clinical isolates of Streptococcus pneumoniae. Mol Microb 1992; 6:2461-2465.
14. Barry AL, Pfaller MA, Fuchs PC, and Packer RR. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from U.S. medical centers in 1992 and 1993. Antimicrob Agents Chemother 1994; 38:2419-2425.
15. Pares S, Mouz N, Petillot Y, Hakenbeck R, and Dideberg O. X-ray structure of Streptococcus pneumoniae pbp2x, a primary penicillin target enzyme. Nature Structural Biology 1996; 3:284-289.
16. Mouz N, Gordon E, Di Guilmi AM, Petit I, Pillot Y et al. Identification of a structural determinant for resistance to β-lactam antibiotics in gram-positive bacteria. Proc Natl Acad Sci USA 1998; 95:13403-13406.
17. Smith AM, and Klugman KP. Alterations in PBP1A essential for high-level penicillin resistance in Streptococcus pneumoniae. Antimicrob Agents Chemother 1998 ; 42:1329-1333.
18. Asahi Y, and Ubukata K. Association of a Thr-371 substitution in a conserved amino acid motif of penicillin-binding protein 1A with penicillin resistance of Streptococcus pneumoniae. Antimicrob Agents Chemother 1998; 42:2267-2273.
19. Filipe SR, and Tomasz A. Inhibition of the expression of penicillin resistance in Streptococcus pneumoniae by inactivation of cell wall muropeptide branching genes. Proc Natl Acad Sci USA 2000; 97:4891-4896.